Top

06-09-2024 | Colorectal Cancer | Original Paper

Enhancing CRC Screening in a Predominantly Hispanic Community: Effectiveness of 1-Day vs. 3-Day Stool-Based Testing Kits

Authors: Jonathan D. Wing, Pracheta Matharasi, Alok Dwivedi, Jennifer Molokwu

Published in: Journal of Community Health

Abstract

Colorectal cancer (CRC) is the leading cause of cancer-related mortality among U.S. Hispanics, with screening proven to decrease both incidence and mortality. Despite rising CRC screening rates in the U.S., Hispanic participation remains disproportionately low. Stool-based tests, particularly popular for reaching underserved populations, may enhance screening adherence. This study evaluates the performance of a 1-day versus a 3-day stool-based testing kit in improving screening completion rates and reducing the need for reminder calls in a Hispanic community along the U.S.-Mexico border. In our quasi-experimental observational study, participants aged 45–75 years who were uninsured or underinsured and overdue for CRC screening were recruited. They received colorectal cancer education and no-cost stool-based screening facilitated by promotoras. Participants were randomly assigned to receive a 1-day or 3-day Fecal Immunochemical Test (FIT) kit. The promotoras swapped FIT kit distribution roles midway through the study period to mitigate performance bias. Our analysis covered 6,660 FITs—3,067 using the 3-day kit and 3,593 with the 1-day kit. Results indicated a higher return rate for the 1-day FIT kit (61.3% vs. 58.7%, adjusted odds ratio [aOR] = 1.22, p < 0.001), fewer reminders needed (69.7% vs. 78.1%, aOR = 0.65, p < 0.001), and lower abnormal FIT results (5.3% vs. 8.1%, aOR = 0.61, p < 0.001). Conclusively, the 1-day FIT kit required fewer reminders and significantly improved return rates, suggesting it may be a more effective option for increasing CRC screening completion among hard-to-reach Hispanic populations.

Rawla, P., Sunkara, T., & Barsouk, A. (2019). Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Przeglad Gastroenterologiczny, 14(2), 89–103. https://doi.org/10.5114/pg.2018.81072CrossRefPubMedPubMedCentral

Gupta, S. (2022). Screening for Colorectal Cancer. Hematology/oncology Clinics of North America, 36(3), 393–414. https://doi.org/10.1016/j.hoc.2022.02.001CrossRefPubMedPubMedCentral

Sharma, I., Kim, S., Sridhar, S., & Basha, R. (2020). Colorectal Cancer: An emphasis on factors influencing Racial/Ethnic disparities. Critical Reviews in Oncogenesis, 25(2), 151–160. https://doi.org/10.1615/CritRevOncog.2020035174CrossRefPubMed

Winkler, C. S., Hardaway, J. C., Ceyhan, M. E., Espat, N. J., & Calvino, S., A (2022). Decreasing colorectal cancer screening disparities: A culturally tailored patient navigation program for hispanic patients. Cancer, 128(9), 1820–1825. https://doi.org/10.1002/cncr.34112CrossRefPubMed

Miller, K. D., Ortiz, A. P., Pinheiro, P. S., Bandi, P., Minihan, A., Fuchs, H. E., Martinez Tyson, D., Tortolero-Luna, G., Fedewa, S. A., Jemal, A. M., & Siegel, R. L. (2021). Cancer statistics for the US Hispanic/Latino population, 2021. CA: A cancer Journal for Clinicians, 71(6), 466–487. https://doi.org/10.3322/caac.21695CrossRefPubMed

National Cancer Institute, Surveillance Research Program (2023, April 19). SEERExplorer: An interactive website for SEER cancer statistics*. [Internet]. Updated June 8, 2023. Cited September 29, 2023. https://seer.cancer.gov/statistics-network/explorer/. Data source(s): SEER Incidence Data, November 2022 Submission (1975–2020), SEER 22 registries; U.S. Mortality Data (1969–2020), National Center for Health Statistics, CDC.

Lin, J. S., Perdue, L. A., Henrikson, N. B., Bean, S. I., & Blasi, P. R. (2021). Screening for Colorectal Cancer: Updated evidence report and systematic review for the US Preventive Services Task Force. Journal of the American Medical Association, 325(19), 1978–1998. https://doi.org/10.1001/jama.2021.4417CrossRefPubMed

Jackson, C. S., Oman, M., Patel, A. M., & Vega, K. J. (2016). Health disparities in colorectal cancer among racial and ethnic minorities in the United States. Journal of Gastrointestinal Oncology, 7(Suppl 1), S32–S43. https://doi.org/10.3978/j.issn.2078-6891.2015.039CrossRefPubMedPubMedCentral

Byrd, T. L., Calderón-Mora, J., Salaiz, R., & Shokar, N. K. (2019). Barriers and facilitators to Colorectal Cancer Screening within a hispanic Population. Hispanic Health Care International: The Official Journal of the National Association of Hispanic Nurses, 17(1), 23–29. https://doi.org/10.1177/1540415318818982CrossRefPubMed

10.

Fernandez, M. E., Wippold, R., Torres-Vigil, I., Byrd, T., Freeberg, D., Bains, Y., Guajardo, J., Coughlin, S. S., & Vernon, S. W. (2008). Colorectal cancer screening among latinos from U.S. cities along the Texas-Mexico border. Cancer Causes & Control: CCC, 19(2), 195–206. https://doi.org/10.1007/s10552-007-9085-6CrossRefPubMed

11.

Diaz, J. A., Roberts, M. B., Goldman, R. E., Weitzen, S., & Eaton, C. B. (2008). Effect of language on colorectal cancer screening among latinos and non-latinos. Cancer epidemiology, biomarkers & prevention: A publication of the American Association for Cancer Research. Cosponsored by the American Society of Preventive Oncology, 17(8), 2169–2173. https://doi.org/10.1158/1055-9965.EPI-07-2692CrossRef

12.

Garcia-Dominic, O., Lengerich, E. J., Wray, L. A., Parrott, R., Aumiller, B., Kluhsman, B., Renderos, C., & Dignan, M. (2012). Barriers to CRC screening among latino adults in Pennsylvania: ACCN results. American Journal of Health Behavior, 36(2), 153–167. https://doi.org/10.5993/AJHB.36.2.2CrossRefPubMed

13.

Natale-Pereira, A., Marks, J., Vega, M., Mouzon, D., Hudson, S. V., & Salas-Lopez, D. (2008). Barriers and facilitators for colorectal cancer screening practices in the latino community: Perspectives from community leaders. Cancer Control: Journal of the Moffitt Cancer Center, 15(2), 157–165. https://doi.org/10.1177/107327480801500208CrossRefPubMed

14.

Aguado Loi, C. X., Tyson, M., Chavarria, D., Gutierrez, E. A., Klasko, L., Davis, L., Lopez, S., Johns, D., Meade, T., C. D., & Gwede, C. K. (2020). Simple and easy:’ providers’ and latinos’ perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening. Ethnicity & Health, 25(2), 206–221. https://doi.org/10.1080/13557858.2017.1418298CrossRef

15.

Oluloro, A., Petrik, A. F., Turner, A., Kapka, T., Rivelli, J., Carney, P. A., Saha, S., & Coronado, G. D. (2016). Timeliness of Colonoscopy after abnormal fecal test results in a Safety Net Practice. Journal of Community Health, 41(4), 864–870. https://doi.org/10.1007/s10900-016-0165-yCrossRefPubMedPubMedCentral

16.

O’Connor, E. A., Nielson, C. M., Petrik, A. F., Green, B. B., & Coronado, G. D. (2020). Prospective cohort study of predictors of Follow-Up Diagnostic Colonoscopy from a pragmatic trial of FIT screening. Scientific Reports, 10(1), 2441. https://doi.org/10.1038/s41598-020-59032-0CrossRefPubMedPubMedCentral

17.

Prakash, S., Merza, N., Hosseini, O., Ward, H., Mansi, T., Balducci, M., Trammell, D., Hernandez, B., & Obokhare, I. (2022). Increasing Fecal Immunochemical Test Return Rates by implementing effective reminder to complete kit communication with participants: A Quality Improvement Study. Cureus, 14(5), e25169. https://doi.org/10.7759/cureus.25169CrossRefPubMedPubMedCentral

18.

Brenner, A. T., Rhode, J., Yang, J. Y., Baker, D., Drechsel, R., Plescia, M., Reuland, D. S., Wroth, T., & Wheeler, S. B. (2018). Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial. Cancer, 124(16), 3346–3354. https://doi.org/10.1002/cncr.31566CrossRefPubMed

19.

Shokar, N. K., Byrd, T., Salaiz, R., Flores, S., Chaparro, M., Calderon-Mora, J., Reininger, B., & Dwivedi, A. (2016). Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly hispanic community. Preventive Medicine, 91, 273–280. https://doi.org/10.1016/j.ypmed.2016.08.039CrossRefPubMed

20.

https://data.census.gov/profile/El_Paso_County,_Texas?g=050XX00US48141

21.

https://data.census.gov/profile/United_States?g=010XX00US

22.

Dwivedi, A. K. (2022). How to write statistical analysis section in medical research. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, 70(8), 1759–1770. https://doi.org/10.1136/jim-2022-002479CrossRefPubMed

23.

Dwivedi, A. K., Mallawaarachchi, I., Lee, S., & Tarwater, P. (2014). Methods for estimating relative risk in studies of common binary outcomes. Journal of Applied Statistics, 41(3), 484–500. https://doi.org/10.1080/02664763.2013.840772CrossRef

24.

Sultanian, R., Du, L., Moysey, B., Morse, A., van Veldhuyzen, S., & Montano-Loza, A. J. (2020). The impact of transitioning from Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program. Journal of the Canadian Association of Gastroenterology, 3(4), 177–184. https://doi.org/10.1093/jcag/gwz009CrossRefPubMed

25.

Chou, A. F., Duncan, A. R., Hallford, G., Kelley, D. M., & Dean, L. W. (2021). Barriers and strategies to integrate medical genetics and primary care in underserved populations: A scoping review. Journal of Community Genetics, 12(3), 291–309. https://doi.org/10.1007/s12687-021-00508-5CrossRefPubMedPubMedCentral

26.

Boguradzka, A., Wiszniewski, M., Kaminski, M. F., Kraszewska, E., Mazurczak-Pluta, T., Rzewuska, D., Ptasinski, A., & Regula, J. (2014). The effect of primary care physician counseling on participation rate and use of sedation in colonoscopy-based colorectal cancer screening program–a randomized controlled study. Scandinavian Journal of Gastroenterology, 49(7), 878–884. https://doi.org/10.3109/00365521.2014.913191CrossRefPubMed

27.

Osborne, J. M., Wilson, C., Duncan, A., Cole, S. R., Flight, I., Turnbull, D., Hughes, D. L., & Young, G. P. (2017). Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: What predicts rescreening? BMC Public Health, 18(1), 81. https://doi.org/10.1186/s12889-017-4634-8CrossRefPubMedPubMedCentral

28.

Rao, S. P., Moralez, E., Livaudais-Toman, J., Lozano, V., & Thompson, B. (2013). Evaluation of a Promotora-led intervention on Colorectal Cancer among hispanics: Findings related to perceptions and communications. Californian Journal of Health Promotion, 11(2), 21–31.CrossRefPubMedPubMedCentral

29.

Moralez, E. A., Rao, S. P., Livaudais, J. C., & Thompson, B. (2012). Improving knowledge and screening for colorectal cancer among hispanics: Overcoming barriers through a PROMOTORA-led home-based educational intervention. Journal of cancer Education: The Official Journal of the American Association for Cancer Education, 27(3), 533–539. https://doi.org/10.1007/s13187-012-0357-9CrossRefPubMed

30.

Goshgarian, G., Sorourdi, C., May, F. P., Vangala, S., Meshkat, S., Roh, L., Han, M. A., & Croymans, D. M. (2022). Effect of patient portal messaging before mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial. JAMA Network open, 5(2), e2146863. https://doi.org/10.1001/jamanetworkopen.2021.46863CrossRefPubMedPubMedCentral

31.

Lee, B., Keyes, E., Rachocki, C., Grimes, B., Chen, E., Vittinghoff, E., Ladabaum, U., & Somsouk, M. (2022). Increased Colorectal Cancer Screening sustained with mailed fecal immunochemical test Outreach. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 20(6), 1326–1333e4. https://doi.org/10.1016/j.cgh.2021.07.022CrossRefPubMed

32.

Pignone, M., Lanier, B., Kluz, N., Valencia, V., Chang, P., & Olmstead, T. (2021). Effectiveness and cost-effectiveness of Mailed FIT in a Safety Net Clinic Population. Journal of General Internal Medicine, 36(11), 3441–3447. https://doi.org/10.1007/s11606-021-06691-yCrossRefPubMedPubMedCentral

33.

Joseph, D. A., King, J. B., Miller, J. W., Richardson, L. C., & Centers for Disease Control and Prevention (CDC). (2012). Prevalence of colorectal cancer screening among adults – behavioral risk factor Surveillance System, United States, 2010. MMWR Supplements, 61(2), 51–56.PubMed

34.

U.S. Census Bureau (2018). 2008–2016 Small Area Health Insurance Estimates (SAHIE) using the American Community Survey (ACS). Retrieved from https://www.census.gov/data/datasets/time-series/demo/sahie/estimates-acs.html

35.

Quintero, E., Castells, A., Bujanda, L., Cubiella, J., Salas, D., Lanas, Á., Andreu,M., Carballo, F., Morillas, J. D., Hernández, C., Jover, R., Montalvo, I., Arenas,J., Laredo, E., Hernández, V., Iglesias, F., Cid, E., Zubizarreta, R., Sala, T., Ponce,M., … COLONPREV Study Investigators (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. The New England journal of medicine, 366(8), 697–706. https://doi.org/10.1056/NEJMoa1108895.

Title: Enhancing CRC Screening in a Predominantly Hispanic Community: Effectiveness of 1-Day vs. 3-Day Stool-Based Testing Kits
Authors: Jonathan D. Wing
Pracheta Matharasi
Alok Dwivedi
Jennifer Molokwu
Publication date: 06-09-2024
Publisher: Springer US
Keywords: Colorectal Cancer
Colorectal Cancer
Published in: Journal of Community Health
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-024-01394-x

Keynote webinar | Spotlight on modern management of frailty

Springer Medicine

Enhancing CRC Screening in a Predominantly Hispanic Community: Effectiveness of 1-Day vs. 3-Day Stool-Based Testing Kits

Abstract

Keynote webinar | Spotlight on modern management of frailty

Springer Medicine

Abstract

Please log in to get access to this content